AVMXY:OTC-Avita Medical Limited (USD)

COMMON STOCK | Other | OTC

Last Closing Price

USD 7.89

Change

0.00 (0.00)%

Market Cap

USD 0.77B

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


Avita Medical Limited (AVMXY) Stock Analysis:
Based on the Avita Medical Limited stock forecasts from 0 analysts, the average analyst target price for Avita Medical Limited is not available over the next 12 months. Avita Medical Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Avita Medical Limited is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, Avita Medical Limited’s stock price was USD 7.89. Avita Medical Limited’s stock price has changed by +0.00 % over the past week, +0.00 % over the past month and +0.00 % over the last year.

About

Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesth ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-02 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SSNLF Samsung Electronics Co. Ltd

N/A

USD15,011.80B 9.00 N/A
DISPF Disco Corporation

N/A

USD3,369.71B 18.60 -488.90
BMYMP Bristol-Myers Squibb Company P..

N/A

USD3,279.86B 8,888.89 N/A
CHKDJ Chesapeake Energy Corporation ..

N/A

USD1,315.84B N/A N/A
BAMKL Bank of America Corporation

N/A

USD267.26B 9.28 N/A
UNLNF Unilever N.V

N/A

USD158.01B 24.49 N/A
LLOBF Lloyds Banking Group plc 9.25%..

N/A

USD134.80B N/A N/A
AZSEY Allianz SE

N/A

USD103.32B 11.82 N/A
NCRRP NCR Corporation 5.5% PFD CNV A

N/A

USD102.22B 720.27 N/A
RNFTF Public Joint Stock Company Ros..

N/A

USD82.94B 10.30 N/A

ETFs Containing AVMXY

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Other)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 319.68% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 319.68% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 115.65% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 115.65% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 195.39% N/A N/A N/A N/A
Risk Adjusted Return 59.19% N/A N/A N/A N/A
Market Capitalization 0.77B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Other)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio -39.72 N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital -143.31% N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.77 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.